{
    "Trade/Device Name(s)": [
        "Dimension\u00ae AHDL Flex\u00ae reagent cartridge",
        "Dimension\u00ae AHDL Method"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "k073072",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032798"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JHM"
    ],
    "Summary Letter Date": "February 21, 2008",
    "Summary Letter Received Date": "January 28, 2008",
    "Submission Date": "January 25, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "High-density lipoprotein cholesterol (HDL-C)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae clinical chemistry system"
    ],
    "Method(s)/Technology(ies)": [
        "PEG-modified enzymatic assay",
        "Two reagent format",
        "Bichromatic endpoint measurement"
    ],
    "Methodologies": [
        "Quantitative enzymatic measurement"
    ],
    "Submission Type(s)": [
        "Reagent Cartridge",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension AHDL Flex reagent cartridge for direct HDL cholesterol measurement using a PEG-modified enzymatic assay on the Dimension clinical chemistry system",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative measurement of HDL cholesterol in human serum and plasma as an aid in diagnosis of lipid disorders, liver and renal diseases, and assessment of risk for atherosclerosis and cardiovascular disease",
    "fda_folder": "Clinical Chemistry"
}